Experiment Analysis & Result Interpretation Questions

Start with a hypothesis-first mindset: offline uplift (+3%) vs online drop (−1%) implies a mismatch between evaluation and production. I would run a fast triage in these categories: data & instrumentation, sampling/overlap, training-serving skew, and targeted experiments.

1. Data & instrumentation checks

• Verify the A/B metric definitions match offline (exact conversion definition, attribution window, dedup rules).
• Compare raw event counts (impressions, clicks, conversions) between experiment and production logs; look for missing events or delayed ingestion.
• Inspect SDK/server versions and rollout config to ensure the correct model/feature set served to treatment.
• Check bucketing keys: consistent hashing, user id used, deterministic assignment.

2. Sampling & holdout issues

• Check sample sizes and power: is −1% statistically significant online? compute p-values, CIs, and minimum detectable effect.
• Look for preview/QA traffic or bots in either group; filter vs include discrepancies.
• Examine holdout overlap: any users exposed to both control and treatment (leakage) or sequential exposures across sessions?

3. Training-serving skew

• Compare feature distributions between training/offline dataset and online serving (missing features, NULL rates, distribution shift).
• Verify feature computation code is identical (same aggregations, timezone, lookback windows).
• Check latency/partial features: real-time pipeline may omit late-arriving labels or features.
• Validate model input pipeline in production with logging: sample inputs, predictions, and downstream outcomes.

4. Logging & consistency tests

• Add per-request tags: model version, feature hashes, bucketing id, seed, and experiment id.
• Log sampled user-level traces linking prediction -> action -> conversion for root-cause tracing.

5. Targeted analyses

• Segment the online effect by cohort (device, geography, user tenure, traffic source) and compare to offline holdouts to find where the mismatch is largest.
• Backtest: replay production logs through the offline model to estimate expected uplift given real inputs.
• Do an imitation experiment: serve model but route signals to metric calculation exactly as offline (same attribution window, filtering).

6. Experiments to run

• Canary with doubled logging and feature shadowing: serve new model but keep a large, fully-instrumented shadow that records predictions and features without affecting treatment.
• Small-scale rollback to previous model vs current for a short period to verify reversal of negative effect.
• Feature-ablation A/B tests: toggle suspect features (or use a simpler model) to isolate which component causes degradation.
• Offline-to-online reconciliation test: for a sample of users, force the offline evaluation pipeline to use live events and compute conversion — compare to online metric.

Decision criteria

• Revert immediately if instrumentation bug, bucketing leak, or a clear production-side bug is found that explains the full delta.
• Gather more evidence (canary + replay) if skew is plausible but not proven; pause ramp if business risk is high.
• Proceed if shadowing and replay show consistent positive signal and online negative is due to low-powered noise or short-term noise; continue with careful monitoring and phased rollout.

Key principle: prefer reproducible explanations (instrumentation, skew, leakage) before attributing to model failure; use log-backed replay and shadowing to close the offline-online loop.

A p-value is the probability of observing data at least as extreme as yours assuming the A and B variants have no true difference (the null hypothesis). In plain terms: if there truly were no effect, a p-value of 0.03 means we'd see results this extreme about 3% of the time due to random chance.

Common misinterpretations and how I rephrase them:

• "P-value is the probability the change works." — Wrong. Rephrase: "A low p-value means the observed difference is unlikely under 'no effect'; it increases confidence there may be a real effect, but doesn't prove it."
• "P>0.05 means no effect." — Wrong. Rephrase: "P>0.05 means we don't have strong evidence to reject 'no effect' given this sample; it might be a small effect or insufficient data."
• "Smaller p-value = bigger business impact." — Wrong. Rephrase: "P-value measures evidence versus chance, not effect size. Look at the conversion lift and confidence interval for business impact."

Best practice: always report the estimated lift, its confidence interval, sample sizes, and the p-value together. Explain uncertainty: "We estimate a 2.1% lift (95% CI: 0.2%–4.0%), p=0.03 — evidence consistent with a small positive effect, but the business impact depends on magnitude and cost to implement."

Situation: The experiment shows a clear win on the primary metric (p = 0.02) but a guardrail metric trends worse with p = 0.06 (borderline non-significant). I treat this as mixed evidence, not a simple go/no-go.

Interpretation and reasoning:

• Statistical significance: Primary metric p=0.02 suggests the uplift is unlikely due to chance. Guardrail p=0.06 is above the conventional 0.05 threshold but close — could be a real effect that the study is underpowered for the guardrail.
• Practical vs statistical: I examine effect sizes and CIs for both metrics. A small but statistically significant uplift might not justify risk if the guardrail degradation is business-critical even if marginal.
• Multiplicity & pre-specification: Verify the guardrail was pre-specified, check multiple comparisons corrections and whether thresholds were adjusted.
• Data quality & assumption checks: Validate instrumentation, look for logging/selection bugs, check randomization balance, and ensure no differential attrition.
• Heterogeneity: Run pre-specified segment analyses (device, geography, user value) to see if degradation concentrates in high-value segments.
• Power analysis: Compute post-hoc power for the guardrail to estimate sample size needed to detect the observed effect with confidence.

Actions I would take before recommending rollout:

1. Re-verify data integrity and randomization.
2. Inspect effect sizes and CIs; quantify expected business impact if guardrail is real.
3. Run sensitivity analyses and subgroup checks to identify affected cohorts.
4. If the guardrail is critical and effect uncertain: extend the experiment or increase sample size to achieve adequate power, or run a targeted follow-up.
5. If rapid rollout is desired but risk exists: recommend a phased rollout (canary) with close monitoring and an automated rollback if guardrail crosses a threshold.
6. Consider Bayesian analysis to estimate probability of harm and communicate risk to stakeholders.

Recommendation: Do not full-rollout immediately. Present balanced evidence (effect sizes, CIs, risk scenarios) and propose either (a) extend the test / run follow-up targeted at the guardrail, or (b) phased rollout with strict monitoring and rollback conditions — choice depends on business risk tolerance and speed-to-market priorities.

Approach (overview): treat fraud as an adversarial bias that inflates observed uplift. I’d quantify incidence, estimate its contribution to uplift, run sensitivity analyses, and integrate uncertainty into go/no-go decisions.

Analyses & metrics:

• Basic signals: conversion rate, average order value (AOV), promo redemptions per account, redemptions per IP/device, new-account share, time-to-redemption distribution.
• Fraud fingerprints: high-frequency redemptions, identical payment instruments, device-ID churn, geolocation clusters, mismatched billing/shipping, velocity rules.
• Comparative metrics: uplift on all users vs. uplift after removing suspected-fraud cohort; ratio of suspicious redemptions to total redemptions; lift-per-cohort (new vs. existing users).
• Statistical checks: compare variance between treatment/control (Levene), run permutation tests excluding suspicious events, and compute adjusted uplift with bootstrapped CIs.
• Modeling: train a supervised fraud model (or use rules) to score events; estimate expected true uplift = observed uplift - expected fraud value (sum(score * txn_value)). Run Bayesian hierarchical model to propagate uncertainty.
• Attack simulation: stress-test by injecting synthetic fraud at various rates to see breakpoint where ROI flips negative.

Decision rules for rollout:

• If estimated fraud contribution is small relative to uplift and adjusted uplift CI > business threshold → proceed full rollout with monitoring.
• If fraud materially reduces or reverses uplift (adjusted uplift ≤ 0) or uncertainty is high → halt or limit to a small, monitored pilot while hardening controls.
• If moderate risk: staged rollout with stricter fraud controls (rate limits, device/email verification, CAPTCHAs) and clear kill-switch metrics (e.g., suspicious-redemptions > X% or delta AOV > Y).

Operationalize:

• Real-time dashboards for fraud signals, automated alerts, and daily recalculation of adjusted uplift.
• Close loop with product/ops to deploy mitigations and re-run analyses.

This balances empirical estimation, uncertainty, and operational safeguards so the promotion can be scaled only when genuine uplift outweighs fraud risk.

Interpretation:

• Because the primary, pre-specified metric is not significant, the experiment did not meet its main effectiveness goal. Two secondary metrics with p<0.05 are likely false positives given you tested 10 secondaries (and one primary) — family-wise error inflates: chance of at least one false positive ≈ 1 − (1−0.05)^10 ≈ 40%.
• These secondary results are hypothesis-generating, not confirmatory.

Statistical steps I recommend:

1. Report effect sizes and 95% CIs for the two significant secondaries (p alone is insufficient).
2. Adjust for multiple comparisons before making confirmatory claims:
   • Conservative: Bonferroni (α' = 0.05/10 = 0.005) — likely makes them non-significant.
   • Less conservative: Benjamini–Hochberg FDR to control expected false discovery rate.
3. Check metric correlations and overlap with the primary (if highly correlated, interpret cautiously; if independent, that changes evidence weight).
4. Perform sensitivity analyses: subgroup consistency, pre-period balance, and robustness to different model specifications.
5. Consider a Bayesian re-analysis (posterior probabilities) which can incorporate priors and give probability of a practically meaningful effect.
6. If you used peeking or sequential looks, apply appropriate corrections (alpha spending or sequential testing methods).

Business / operational steps:

1. Treat the two secondaries as hypotheses to validate. Do not roll out product changes based solely on them.
2. Prioritize follow-up experiments: pre-specify one or two of these secondary metrics as new primary outcomes and run a replication A/B test with sufficient power to detect the observed effect sizes.
3. Assess business significance — are the effect sizes large enough to justify implementation cost even if real?
4. Investigate causal plausibility and mechanism with qualitative data or instrumentation (event logs, user flows).
5. Communicate transparently to stakeholders: state that primary failed, secondaries are exploratory, and outline planned confirmatory steps and timelines.
6. If speed of decision matters and the cost of being wrong is low, consider a guarded rollout (canary) combined with close monitoring and pre-registered metrics.

Bottom line: don’t over-interpret unadjusted p<0.05 on multiple secondaries. Re-analyze with corrections, quantify practical impact, and run a pre-registered replication before scaling.